KalVista Pharmaceuticals (KALV) Shares Outstanding (2017 - 2024)
Historic Shares Outstanding for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q4 2024 value amounting to $49.4 million.
- KalVista Pharmaceuticals' Shares Outstanding changed N/A to $49.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $49.4 million, marking a year-over-year change of. This contributed to the annual value of $42.5 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Shares Outstanding is $49.4 million.
- KalVista Pharmaceuticals' Shares Outstanding's 5-year high stood at $49.4 million during Q4 2024, with a 5-year trough of $17.8 million in Q1 2020.
- Over the past 4 years, KalVista Pharmaceuticals' median Shares Outstanding value was $34.3 million (recorded in 2023), while the average stood at $30.9 million.
- Per our database at Business Quant, KalVista Pharmaceuticals' Shares Outstanding surged by 36.44% in 2020 and then skyrocketed by 2572.57% in 2024.
- KalVista Pharmaceuticals' Shares Outstanding (Quarter) stood at $17.9 million in 2020, then grew by 0.59% to $18.0 million in 2021, then soared by 91.01% to $34.4 million in 2023, then soared by 43.61% to $49.4 million in 2024.
- Its Shares Outstanding stands at $49.4 million for Q4 2024, versus $43.3 million for Q4 2024 and $43.1 million for Q3 2024.